[ad_1] Reviewed by Emily Henderson, B.Sc.November 16, 2020 The first ever randomized Phase 3 clinical trial in patients with advanced anal canal cancer is now open and enrolling patients. Anal cancer is a rare disease. The vast majority (90%) of new cases are of the squamous cell type, associated with …
Read More »The first Phase 3 advanced anal cancer study opens for patient enrollment
